复方参七汤对胃结直肠癌抑制作用的实验研究（临床医学范文）.docVIP

下载本文档

2
0
约1.34万字
约 17页
2022-11-23 发布于广东
举报
版权申诉

复方参七汤对胃结直肠癌抑制作用的实验研究（临床医学范文）.doc

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

复方参七汤对胃结直肠癌抑制作用的实验研究（临床医学范文）目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：复方参七汤对胃结直肠癌抑制作用的实验研究 1 1 材料与方法 3 1.2 方法 3 2: 5-GTTTTCTGCGCAAGGTTAGG-3 6 文2：复方参七汤对胃结直肠癌抑制作用的实验研究临床医学论文 6 1 材料与方法 8 1.2 方法 8 2: 5-GTTTTCTGCGCAAGGTTAGG-3 11 2 结果 11 3 讨论 13 参考文摘引言： 14 原创性声明（模板） 16 文章致谢（模板） 16 正文复方参七汤对胃结直肠癌抑制作用的实验研究（临床医学范文）文1：复方参七汤对胃结直肠癌抑制作用的实验研究 [Abstract] Objective: To investigate the mechanism of therapeutic effect of compound Shenqitang on the gastric and colorectal carcinomas. Methods: Several experiments had been done, including:(1) the inhibitory effect of compound Shenqitang on human gastric adenocarcinoma cell line in vitro；(2) its inhibitory effects on Wistar rat gastric adenocarcinoma induced by MNNG; and (3) its inhibitory effect on the hepatic metastases of colorectal carcinoma in mice. Results: （1）Obvious inhibitory effects of compound Shenqitang had been found on the cell division and colony form of human gastric adenocarcinoma cell line BGC-823 in vitro. The LC50 was 0.007g crude drug/ml in colony form experiment. The drug had potent killing effect in higher concentration, with LC50 of 0.048g crude drug/ml；（2）The incidence of gastric adenocarcinoma in the experimental group(6.9%) was significantly lower than that in the control group(58.9%).The positive rates of PCNA and cyclin D1 in the experimental group were 13.88%(5/36) and 22.86%(8/35), which were significantly lower than those in the control group（P0.01)；（3）Compound Shenqitang inhibited hepatic metastases of colorectal carcinoma in mouse model. Nm23H1-NDPK positive expression rate (66.67%) was significantly higher in the experimental group than that (16.67%) in the control group（P0.05). Conclusion: Compound Shenqitang can effectively kill the human gastric adnocarcinoma cell line BGC-823 in vitro, inhibit the incidence of the gastric adenocarcinoma induced by MNNG in Wistar rats, and inhibit hepatic metastasis of colon carcinoma in mouse model. [Key words] Gastric carcin